Novel hypoglycemic compounds from wild mushroom Paxillus involutus

Jianhua Lv,Lan Yao,Dan Li,Chuanwen Jia,Jinxiu Zhang,Li-An Wang,Changtian Li,Yu Li,Li-an Wang
DOI: https://doi.org/10.1016/j.bioorg.2021.104984
IF: 5.307
2021-07-01
Bioorganic Chemistry
Abstract:<p>Wild mushrooms are an important source of secondary metabolites possessing a broad range of biological activities. In this study, eight new compounds, named furanopaxin A–F (<strong>1</strong>–<strong>6</strong>), deoxybisinvolutone (<strong>7</strong>), and coumarinvol (<strong>8</strong>) along with two known compounds were isolated from fruiting bodies of the wild mushroom <em>Paxillus involutus</em> (Batsch) Fr. Their structures were established based on HR-ESI-MS and 1D and 2D NMR spectroscopic data. The results of hypoglycemic assays indicated that compounds <strong>5</strong>–<strong>8</strong> possessed significant α-glucosidase inhibitory activities, with IC<sub>50</sub> values ranging from 14.65 ± 1.68 to 47.55 ± 1.47 μM, and each compound could enhance glucose consumption in insulin-resistance HepG2 cells. Further analysis by molecular docking implied that compounds <strong>5</strong>–<strong>8</strong> could interact with the amino acid residues of α-glucosidase, supporting the hypoglycemic activity of the compounds.</p>
biochemistry & molecular biology,chemistry, organic
What problem does this paper attempt to address?